Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Mehta is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
UPMC Medical EducationFellowship, Hospice and Palliative Medicine, 2009 - 2010
Mercy Catholic Medical CenterResidency, Internal Medicine, 2006 - 2009
Government Medical College PatialaClass of 2003
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2016 - 2026
WA State Medical License 2022 - 2025
OK State Medical License 2020 - 2021
MN State Medical License 2015 - 2017
PA State Medical License 2006 - 2014
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Clinical Trials
- Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant Start of enrollment: 2021 Oct 08
Publications & Presentations
PubMed
- Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.George L Chen, Roland Bassett, Rohtesh S Mehta, Betul Oran, Fareed Khawaja
American Journal of Hematology. 2026-08-01 - Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy.Yosra M Aljawai, Kai Cao, Jun Zou, Yudith Carmazzi, Amin Alousi
Bone Marrow Transplantation. 2026-06-17 - Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes.Uday R Popat, Konstantinos Lontos, Roland Bassett, Jitesh Kawedia, Ben C Valdez
Transplantation and Cellular Therapy. 2026-06-12
Journal Articles
- Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction DrugsKrina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
Abstracts/Posters
- Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell TransplantationRohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Do...Rohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS PatientsRohtesh S. Mehta, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Guest Editorial: Advances in Immunotherapy for Hematological MalignanciesFebruary 9th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










